BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $12,599,000 | -3.1% | 12,228,000 | 0.0% | 0.08% | -15.3% |
| Q2 2018 | $13,000,000 | +3.7% | 12,228,000 | 0.0% | 0.10% | -7.5% |
| Q1 2018 | $12,537,000 | -5.2% | 12,228,000 | 0.0% | 0.11% | -7.8% |
| Q4 2017 | $13,218,000 | -3.1% | 12,228,000 | 0.0% | 0.12% | +3.6% |
| Q3 2017 | $13,634,000 | +0.6% | 12,228,000 | 0.0% | 0.11% | -5.9% |
| Q2 2017 | $13,547,000 | -2.0% | 12,228,000 | 0.0% | 0.12% | +4.4% |
| Q1 2017 | $13,830,000 | +0.7% | 12,228,000 | 0.0% | 0.11% | -16.3% |
| Q4 2016 | $13,733,000 | -6.1% | 12,228,000 | 0.0% | 0.14% | +1.5% |
| Q3 2016 | $14,630,000 | +7.8% | 12,228,000 | 0.0% | 0.13% | -6.3% |
| Q2 2016 | $13,573,000 | -3.9% | 12,228,000 | 0.0% | 0.14% | -4.7% |
| Q1 2016 | $14,125,000 | -10.0% | 12,228,000 | 0.0% | 0.15% | +14.6% |
| Q4 2015 | $15,698,000 | -1.3% | 12,228,000 | 0.0% | 0.13% | -11.6% |
| Q3 2015 | $15,899,000 | -16.1% | 12,228,000 | 0.0% | 0.15% | -11.4% |
| Q2 2015 | $18,940,000 | +5.4% | 12,228,000 | 0.0% | 0.17% | +11.4% |
| Q1 2015 | $17,970,000 | +22.1% | 12,228,000 | -2.2% | 0.15% | -0.7% |
| Q4 2014 | $14,715,000 | +11.5% | 12,500,000 | 0.0% | 0.15% | -9.6% |
| Q3 2014 | $13,203,000 | +2.4% | 12,500,000 | 0.0% | 0.17% | +5.1% |
| Q2 2014 | $12,895,000 | -5.9% | 12,500,000 | 0.0% | 0.16% | -9.2% |
| Q1 2014 | $13,699,000 | +3.3% | 12,500,000 | 0.0% | 0.17% | -7.0% |
| Q4 2013 | $13,262,000 | – | 12,500,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|